We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CIRS, Aquilab Partner to Advance Integrated Phantom-Software for Medical Physicists

By HospiMedica International staff writers
Posted on 07 Aug 2012
CIRS (Norfolk, VA, USA) and Aquilab (Lille, France) reported on the establishment a strategic partnership that will build upon each company’s history of innovations in phantom technologies and image analysis software, respectively. More...


The first result of this partnership, ISO Analyze image analysis software, was released by CIRS during the 2012 American Association of Physicists in Medicine (AAPM) annual meeting held in Charlotte (NC, USA), July 29 through August 2, 2012. ISO analyze image analysis software integrates with the ISO Cube Daily quality assurance (QA) phantom and ISO (International Organization for Standardization) base alignment platform, enabling user-friendly quality control of the isocenter of a LINAC (linear accelerator) by analyzing Digital Imaging and Communications in Medicine (DICOM) images acquired with the EPID (electronic portal imaging device) detector. Controls are run automatically, analyzing the image of the ISO Cube and quantifying a large number of evaluation parameters. It allows users to generate a report for each preceding control.

“Our new partnership with Aquilab will allow us to bring affordable, high quality, ‘turnkey’ solutions to common challenges such as isocenter coincidence while remaining focused on our core competencies in phantom design and development,” said CIRS Mark Devlin, president and CEO of CIRS.

“This partnership with CIRS allows us to promote worldwide the technology we have developed for the automated image analysis of test objects, aiming at improving QA of medical devices. It is also an opportunity for us to work with a leading manufacturer of phantoms in the scope of our international development,” said David Gibon, president and CEO of Aquilab. Aquilab also exhibited their full range of software solutions during the 2012 AAPM annual meeting.

CIRS is known worldwide for tissue simulation technology and is a manufacturer of phantoms and simulators for quantitative densitometry, calibration, quality control, and research in the field of medical imaging and radiotherapy.

Aquilab develops sophisticated software solutions for quality assurance of medical imaging and radiotherapy equipment and the evaluation of radiotherapy treatments. With more than 250 installations in Europe, Aquilab has become recognized in the market of QA software solutions for medical devices and is rapidly growing in the market of radiotherapy for the preparation and evaluation of plans and the management of clinical trials.

Related Links:

CIRS
Aquilab



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.